MedPath

MITSUI MEMORIAL HOSPITAL

🇯🇵Japan
Ownership
Private
Established
1906-01-01
Employees
-
Market Cap
-
Website
http://www.mitsuihosp.or.jp

Clinical Trials

20

Active:0
Completed:7

Trial Phases

2 Phases

Phase 4:2
Not Applicable:18

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (20 trials with phase data)• Click on a phase to view related trials

Not Applicable
18 (90.0%)
Phase 4
2 (10.0%)

DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure

Phase 4
Completed
Conditions
Heart Failure
Diabetes Mellitus
Interventions
Drug: Suspending DPP-4 inhibitor, in outpatient service
Drug: Starting DPP-4 inhibitor after treatment of heart failure
Drug: Suspending DPP-4 inhibitor after treatment of heart failure
First Posted Date
2014-12-09
Last Posted Date
2018-03-22
Lead Sponsor
Mitsui Memorial Hospital
Target Recruit Count
10
Registration Number
NCT02312427
Locations
🇯🇵

Mitsui Memorial Hospital, Taito-ku, Tokyo, Japan

Effect of Combination of Non-sLip Element Balloon (NSE) and druG-coated bAlloon (DCB) for In-steNT Restenosis Lesions

Phase 4
Conditions
Coronary Restenosis
First Posted Date
2014-11-25
Last Posted Date
2017-03-23
Lead Sponsor
Mitsui Memorial Hospital
Target Recruit Count
210
Registration Number
NCT02300454
Locations
🇯🇵

Tokai University, Isehara, Kanagawa, Japan

🇯🇵

Mitsui Memorial Hospital, Chiyoda-Ku, Tokyo, Japan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.